Skip to main content
OpenTrials
Completed

NCT Number: NCT02905175

Rheumatoid Arthritis Patients and Porphyromonas Gingivalis

Rheumatoid arthritis (RA) is the most frequent joint inflammatory disease inducing joint destruction strongly correlated with anti-citrullinated protein antibodies citrullinated anti-peptide (ACPA). Precise RA etiology remained unclear with a described association between RA and periodontal disease. The missing link could be a gram-negative anaerobic bacterium called Porphyromonas gingivalis (P. gingivalis), which is heavily involved in periodontal disease and able to induce gingival citrullinated protein via an enzyme called peptidyl arginine deiminase (PAD). DNA of P. gingivalis was detected in synovial tissue and in peripheral blood mononuclear cell. To improve knowledge of P. gingivalis involvement in RA, the investigators will compare its effect on various cell type with comparison with another oral bacteria Provatella intermedia.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

CHU Saint-Etienne

Saint-Etienne, 42055, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age >18 ans
  • RA or osteoarthritis with joint surgery planned
  • Informed consent approved and signed

Exclusion criteria

  • Pregnancy

Treatment and study plan

Blood sample

Procedure

synovial tissue

Procedure

synoviocytes from synovial tissue

Primary outcomes

  1. Comparison of genetic signature after induction by P. gingivalis and P. intermedia on synoviocytes

    Time frame: day 1

Secondary outcomes

  1. Comparison of specific transcriptome profile induced by P. gingivalis compared to P. intermedia on peripheral blood mononuclear cells (PBMC) and gingival fibroblasts

    Time frame: day 1

  2. Comparison of transcriptome profile between P. gingivalis and P. intermedia on RA synovial cells.

    Time frame: day 1

  3. Comparison of the transcriptomic profile between RA and osteoarthritis synoviocytes

    Time frame: day 1

Sponsors and collaborators

Lead sponsor

Centre Hospitalier Universitaire de Saint Etienne

Other

Registry information

Official study title

Porphyromonas Gingivalis Contribution in Rheumatoid Arthritis (RA).

Important dates

Study start
2016
Primary completion
2016
Study completion
2016
First posted
Sep 19, 2016
Registry last updated
Jul 26, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.